Literature DB >> 8828622

Psychosocial aspects in phenylketonuria.

J Weglage1, B Fünders, K Ullrich, A Rupp, E Schmidt.   

Abstract

Psychosocial aspects in phenylketonuric (PKU) patients are reported. In two separate studies patients with PKU differing in age (children versus adolescents), were assessed. The main message of the first prospective study on 58 10-year-old patients is that normally intelligent PKU patients who were treated early and strictly did not show a higher risk for severe emotional and behavioural maladjustment compared with healthy controls at the age of 10 years. The data were obtained in the course of the German PKU Collaborative Study by the "Personality Questionnaire for Children (PFK 9-14)". All patients received nutritional, medical, and psychological counselling every 6 months. In the second retrospective study, 34 early treated, normally intelligent adolescents with PKU (age: mean = 14.6, SD = 2.0, range = 11-18 years) and their mothers were assessed with several psychometric personality inventories and self-developed questionnaires concerning their psychosocial situation and their disease- and diet-specific knowledge. Using the Mannheimer Biographic Inventory (MBI), the Personality Questionnaire for Children (PFK 9-14), and the Freiburger Personality Inventory (FPI) the adolescent patients described their social life and their emotional development as being distinctly restricted. Their knowledge concerning disease and diet was alarmingly poor and the majority had great difficulties in satisfactory dietetic management without parental help. In addition to the burdensome diet, developmental crises like puberty may cause more frequently emotional and behavioural problems in PKU patients.

Entities:  

Mesh:

Year:  1996        PMID: 8828622     DOI: 10.1007/pl00014225

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  6 in total

1.  Behavior disturbance in 8-year-old children with early treated phenylketonuria. Report from the MRC/DHSS Phenylketonuria Register.

Authors:  I Smith; M G Beasley; O H Wolff; A E Ades
Journal:  J Pediatr       Date:  1988-03       Impact factor: 4.406

2.  Psychosocial factors in phenylketonuria.

Authors:  A C Wood; C J Friedman; I M Steisel
Journal:  Am J Orthopsychiatry       Date:  1967-07

3.  Psychiatric diagnosis and behavioral characteristics of phenylketonuric children.

Authors:  G M Realmuto; B D Garfinkel; M Tuchman; M Y Tsai; P N Chang; R O Fisch; S Shapiro
Journal:  J Nerv Ment Dis       Date:  1986-09       Impact factor: 2.254

4.  Psychological and social findings in adolescents with phenylketonuria.

Authors:  J Weglage; B Fünders; B Wilken; D Schubert; E Schmidt; P Burgard; K Ullrich
Journal:  Eur J Pediatr       Date:  1992-07       Impact factor: 3.183

5.  Psychopathology of patients treated early for phenylketonuria: results of the German collaborative study of phenylketonuria.

Authors:  P Burgard; M Armbruster; E Schmidt; A Rupp
Journal:  Acta Paediatr Suppl       Date:  1994-12

6.  Personality characteristics in patients with phenylketonuria treated early.

Authors:  J Weglage; A Rupp; E Schmidt
Journal:  Pediatr Res       Date:  1994-05       Impact factor: 3.756

  6 in total
  10 in total

1.  Influence of knowledge of the disease on metabolic control in phenylketonuria.

Authors:  Jolita Bekhof; Francjan J van Spronsen; Matty R Crone; Margreet van Rijn; Carin G M Oudshoorn; Paul H Verkerk
Journal:  Eur J Pediatr       Date:  2003-04-08       Impact factor: 3.183

2.  Executive function in treated phenylketonuria as measured by the one-back and two-back versions of the continuous performance test.

Authors:  P Griffiths; R Campbell; P Robinson
Journal:  J Inherit Metab Dis       Date:  1998-04       Impact factor: 4.982

3.  Wechsler subscale IQ and subtest profile in early treated phenylketonuria.

Authors:  P V Griffiths; C Demellweek; N Fay; P H Robinson; D C Davidson
Journal:  Arch Dis Child       Date:  2000-03       Impact factor: 3.791

4.  Behavioural and emotional problems in early-treated adolescents with phenylketonuria in comparison with diabetic patients and healthy controls.

Authors:  J Weglage; M Grenzebach; M Pietsch; R Feldmann; R Linnenbank; J Denecke; H G Koch
Journal:  J Inherit Metab Dis       Date:  2000-07       Impact factor: 4.982

5.  The course of life and quality of life of early and continuously treated Dutch patients with phenylketonuria.

Authors:  A M Bosch; W Tybout; F J van Spronsen; H W de Valk; F A Wijburg; M A Grootenhuis
Journal:  J Inherit Metab Dis       Date:  2006-12-11       Impact factor: 4.982

6.  Blood phenylalanine concentrations in patients with PAH-deficient hyperphenylalaninaemia off diet without and with three different single oral doses of tetrahydrobiopterin: assessing responsiveness in a model of statistical process control.

Authors:  M Lindner; G Gramer; S F Garbade; P Burgard
Journal:  J Inherit Metab Dis       Date:  2009-06-10       Impact factor: 4.982

7.  Cognitive functioning and psychiatric disorders in children with a metabolic disease.

Authors:  Annik Simons; François Eyskens; Ann De Groof; Ellen Van Diest; Dirk Deboutte; Robert Vermeiren
Journal:  Eur Child Adolesc Psychiatry       Date:  2006-03-10       Impact factor: 4.785

8.  Effects and clinical significance of tetrahydrobiopterin supplementation in phenylalanine hydroxylase-deficient hyperphenylalaninaemia.

Authors:  G Gramer; P Burgard; S F Garbade; M Lindner
Journal:  J Inherit Metab Dis       Date:  2007-08-06       Impact factor: 4.982

Review 9.  The complete European guidelines on phenylketonuria: diagnosis and treatment.

Authors:  A M J van Wegberg; A MacDonald; K Ahring; A Bélanger-Quintana; N Blau; A M Bosch; A Burlina; J Campistol; F Feillet; M Giżewska; S C Huijbregts; S Kearney; V Leuzzi; F Maillot; A C Muntau; M van Rijn; F Trefz; J H Walter; F J van Spronsen
Journal:  Orphanet J Rare Dis       Date:  2017-10-12       Impact factor: 4.123

10.  Phenylketonuria patients' and their parents' acceptance of the disease: multi-centre study.

Authors:  Ewa Witalis; Bożena Mikoluc; Radoslaw Motkowski; Justyna Szyszko; Agnieszka Chrobot; Bozena Didycz; Agata Lange; Renata Mozrzymas; Andrzej Milanowski; Maria Nowacka; Mariola Piotrowska-Depta; Hanna Romanowska; Ewa Starostecka; Jolanta Wierzba; Magdalena Skorniewska; Barbara Iwona Wojcicka-Bartlomiejczyk; Maria Gizewska
Journal:  Qual Life Res       Date:  2016-05-31       Impact factor: 4.147

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.